Avepoint vs Cellebrite DI
Avepoint and Cellebrite DI are similar in size: $419m and $476m of revenue in their latest fiscal years. Avepoint grew faster (26.9% against 18.6%). Cellebrite DI kept more of each dollar of sales as profit: a net margin of 16.5% against 8.3%.
| Latest fiscal year | AvepointAVPT, 2025 | Cellebrite DICLBT, 2025 |
|---|---|---|
| Revenue | $419m | $476m |
| Revenue growth | 26.9% | 18.6% |
| Net income | $34.8m | $78.3m |
| Operating margin | — | 14.0% |
| Net margin | 8.3% | 16.5% |
| Return on equity | 9.3% | 19.1% |
| Free cash flow | $81.6m | $160m |
| Cash | $481m | $124m |
| Total debt | $0 | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $49.8m | — |
| Employees | 3,443 | — |
| Market value | $3.50bn | $3.03bn |
| Price vs our value range | Above our value range | Below our value range |
| Moat score | 42 (Weak) | — |
| Insider trades, 12 months | 0 buys, 18 sales | 0 buys, 15 sales |